Blog
Fossil Gets Buried As Business Conditions Remain Tough
Fossil Group (NASDAQ: FOSL) has suffered through one of the worst periods of its history recently. The fashion-conscious watchmaker benefited greatly from past periods of popularity for watches and
Germany and U.K. Drive Liberty Global plc Growth in Q2
Europe's steady economic improvement continues to be a tailwind for Liberty Global plc (NASDAQ: LBTYK) and some of the company's new products are taking hold as well.As the telecommunications business
Why Amedisys Shares Slumped 24.6% in July
Amedisys Inc. (NASDAQ: AMED) shares lost nearly 25% of their value last month, according to S&P Global Market Intelligence. The drop was caused by word that the the federal government's Centers for
U.S. International Trade Commission to Investigate Qualcomm Complaint Against Apple
The U.S International Trade Commission (ITC) announced on Tuesday that it has voted to investigate Qualcomm's (NASDAQ: QCOM) complaints of patent infringement by Apple (NASDAQ: AAPL). The mobile chip
3 Key Takeaways from Cirrus Logic's Earnings Report
Audio chip developer Cirrus Logic (NASDAQ: CRUS) delivered a relatively low-drama earnings report on Aug. 2, with results coming in largely as expected. While the company managed to grow revenue by
5 Things Kratos Management Wants You to Know
When Kratos Defense & Security Solutions (NASDAQ: KTOS) reported its fiscal Q2 earnings last week, investors rebelled. GAAP profits, promised three months ago, had failed to materialize. More promises
Facebook Stock Split: Everything You Need to Know
"Hold up. Wasn't Facebook (NASDAQ: FB) going to split its stock?"It's a fair question. And it deserves some fresh analysis.Facebook's stock split was approved a while ago. Indeed, it was the summer of
1 Airline That Should Buy Back More Stock -- and 1 That Should Buy Back Less
In the past few years, U.S. airlines' profits have surged due to a combination of moderate oil prices and strong demand. Many airlines have taken advantage of their rising cash flow to buy back lots
3 High-Yield Bank Stocks
Thanks to the current low-interest-rate environment, most banking products such as CDs and savings accounts don't pay very much. On the other hand, many bank stocks pay their investors exceptionally
3 Great Reasons to Buy Applied Optoelectronics Stock Right Now
Owning shares of Applied Optoelectronics (NASDAQ: AAOI) isn't for the faint of heart. The maker of fiber-optic lasers and networking components has rewarded shareholders with a 410% gain over the last
Monster Beverage Falls Flat Despite Record Sales
For companies that are considered the growth darlings of the stock market, higher revenue is not enough. Growth rates also have to remain strong, and energy-drink giant Monster Beverage (NASDAQ: MNST)
5 Top Stocks for August
The summer season is quickly coming to a close, but that doesn't mean we'll stop our never-ending quest to find market-beating stocks.To that end, we asked five top Motley Fool investors to pick
Sun Hydraulics Is Investing More in Growth in 2017
Sun Hydraulics Corporation (NASDAQ: SNHY) reported earnings after the market closed on Monday, and it didn't disappoint investors. Growth in demand for hydraulic and industrial electronics products is
Priceline Keeps Growing, but Guidance Again Disappoints
Some companies develop a pattern in how they communicate their financial results to investors. Online travel specialist Priceline Group (NASDAQ: PCLN) takes a predictable tack toward reporting its
Why the "Network Effect" is Crucial for TripAdvisor
TripAdvisor (NASDAQ: TRIP) is the largest online travel review site and may be of interest to contrarian investors. The stock is down almost 45% in the past 12 months, yet the company sports one of
5 Highly Respected Investors Who Are Worried About the Market Right Now
If you think the stock market is high right now, you're in good company. Some of the world's most revered investors are saying the very same thing.Investors should consider the wisdom of people like
Why Tenet Healthcare Shares Dropped 14.4% Today
After reporting second-quarter earnings and offering up guidance for 2017, shares of Tenet Healthcare (NYSE: THC) have fallen 14.6% as of 2:30 p.m. EDT on Tuesday.Tenet Healthcare's year-over-year
Why J.C. Penney Company, Inc. Stock Jumped 16% Last Month
Shares of J.C. Penney Company, Inc. (NYSE: JCP) bounced back last month. The stock rose both on better news in the retail industry, and because it was perceived as a value play after falling sharply
The Key Reason Alexion Pharmaceuticals, Inc. Vaulted 13% Higher in July
Shares of Alexion Pharmaceuticals (NASDAQ: ALXN), a biotech company with a keen focus on developing therapies to treat ultra-rare diseases, moved steadily higher by 13% during the month of July
What Happened in the Stock Market Today
Stocks pulled back modestly today, with the Dow Jones Industrial Average (DJINDICES: ^DJI) dropping for the first time in 10 sessions while the S&P 500 (SNPINDEX: ^GSPC) incurred a similarly small
Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today
Investors saw the end of a historic bullish streak for stocks on Tuesday, as the Dow Jones Industrials failed in their bid for a 10th straight day of record-setting gains. Instead, major benchmarks
Why Ralph Lauren, LendingClub, and FibroGen Jumped Today
Tuesday was a letdown for investors, with stocks spending much of the day in positive territory but then giving up ground toward the end of the trading session. Major benchmarks fell roughly 0.15% to
Why MercadoLibre's Second-Quarter Profit Problem Is Probably Just a Hiccup
In this segment from Motley Fool Money, host Chris Hill, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann look beyond the headline numbers as they consider the investment
Argus Upgrades Tesla, Sets $444 Price Target
Shares of Tesla (NASDAQ: TSLA) jumped today thanks to an analyst upgrade. Argus Research analyst Bill Selesky has now boosted his rating on shares of the electric-car maker from hold to buy, while
MyoKardia Inc. Is on the Rise Again Today -- Here's Why
After a monster run-up on Monday, MyoKardia Inc. (NASDAQ: MYOK) climbed another 145.9% as of 3:30 p.m. during Tuesday's session. It seems investors still giddy about positive clinical trial data